| Roche Pharma (Schweiz) AG - Mircera 120 ug / 0.3 ml, Injektionslösung in einer Fertigspritze |
| 57860 | | 13 | | Mircera 120 ug / 0.3 ml | | Injektionslösung in einer Fertigspritze | | B03XA03 | | Methoxy Polyethylene Glycol-Epoetin Beta | | 10.09.2008 | | |
|
| Composition |
| methoxy polyethylene glycol-epoetinum beta 120 µg, natrii sulfas anhydricus, natrii dihydrogenophosphas monohydricus, mannitolum, poloxamerum 188, acidum hydrochloricum q.s. ad pH, natrii hydroxidum q.s. ad pH, methioninum, aqua ad iniectabile q.s. ad solutionem pro 0.3 ml corresp. natrium 0.62 mg. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Methoxy Polyethylene Glycol-Epoetinum Beta | 120 µg |
| | BAG: Active Agent | Dose |
|---|
| Methoxy Polyethylene Glycol-Epoetinum beta | 120 mcg |
| | | | Inactive agents | Dose |
|---|
| Hydrochloric Acid | | | Mannitol | | | Sodium Dihydrogenophosphate Monohydrate | | | Sodium Sulfate Anhydrate | | | Poloxamer | 188 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 021 | 0.3 ml | 216.34 | 251.70 | A | SL | Yes |
|
